Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications

References

• Chalasani N , Younossi Z , Lavine JE , et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology . 2012;55:2005–2023. doi:10.1002/hep.25762 22488764
   PubMed Web of Science ®Google Scholar
• Starley BQ , Calcagno CJ , Harrison SA . Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology . 2010;51:1820–1832. doi:10.1002/hep.23594 20432259
   PubMed Web of Science ®Google Scholar
• Regnell SE , Lernmark Å . Hepatic steatosis in type 1 diabetes. Rev Diabet Stud . 2011;8:454–467. doi:10.1900/RDS.2011.8.454 22580727
   PubMedGoogle Scholar
• Targher G , Mantovani A , Pichiri I , et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes. Diabetes Care . 2014;37:1729–1736. doi:10.2337/dc13-2704 24696459
   PubMed Web of Science ®Google Scholar
• Mantovani A , Mingolla L , Rigolon R , et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes. Int J Cardiol . 2016;225:387–391. doi:10.1016/j.ijcard.2016.10.040 27768965
   PubMed Web of Science ®Google Scholar
• Mantovani A , Rigolon R , Mingolla L , et al. Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes. J Diabetes Complications . 2017;31:1021–1026. doi:10.1016/j.jdiacomp.2017.01.024 28254449
   PubMed Web of Science ®Google Scholar
• Kahl S , Straßburger K , Nowotny B , et al. Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance. PLoS One . 2014;9:e94059. doi:10.1371/journal.pone.0094059 24732091
   PubMed Web of Science ®Google Scholar
• Bedogni G , Bellentani S , Miglioli L , et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol . 2006;6:33. doi:10.1186/1471-230X-6-33 17081293
   PubMed Web of Science ®Google Scholar
• Lee JH , Kim D , Kim HJ , et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis . 2010;42: 503–508. doi:10.1016/j.dld.2009.08.002 19766548
   PubMedGoogle Scholar
• Sviklāne L , Olmane E , Dzērve Z , Kupčs K , V V P , Sokolovska J . Fatty liver index and hepatic steatosis index predict non-alcoholic fatty liver disease in type 1 diabetes. J Gastroenterol Hepatol . 2018;33:270–276.28464337
   PubMed Web of Science ®Google Scholar
• Irace C , Scarinci F , Scorcia V , et al. Association among low whole blood viscosity, haematocrit, haemoglobin and diabetic retinopathy in subjects with type 2 diabetes. Br J Ophthalmol . 2011;95: 94–98. doi:10.1136/bjo.2009.172601 20530659
   PubMed Web of Science ®Google Scholar
• Carallo C , Tripolino C , De Franceschi MS , Irace C , Xu XY , Gnasso A . Carotidendothelial shear stress reduction with aging is associated with plaque development in twelve years. Atherosclerosis . 2016;251:63–69. doi:10.1016/j.atherosclerosis.2016.05.048 27266823
   PubMed Web of Science ®Google Scholar
• Associazione Medici Diabetologi (AMD) - Società Italiana di Diabetologia (SID). Standard italiani per la cura del diabete mellito; 2018 Available from: www.siditalia.it.
   Google Scholar
• Lim AKH . Diabetic nephropathy – complications and treatment. Int J Nephrol Renovasc Dis . 2014;7:361–381.25342915
   PubMedGoogle Scholar
• Hazlehurst JM , Woods C , Marjot T , Cobbold JF , Tomlinson JW . Non-alcoholic fatty liver disease and diabetes. Metabolism . 2016;65:1096–1108. doi:10.1016/j.metabol.2016.01.001 26856933
   PubMed Web of Science ®Google Scholar
• Benedict M , Zhang X . Non-alcoholic fatty liver disease: an expanded review. World J Hepatol . 2017;9:715–732. doi:10.4254/wjh.v9.i16.715 28652891
   PubMed Web of Science ®Google Scholar
• Petit JM , Pedro L , Guiu B , et al. Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis. Diabet Med . 2015;32:1648–1651. doi:10.1111/dme.12805 25981893
   PubMed Web of Science ®Google Scholar
• Cusi K , Sanyal AJ , Zhang S , et al. Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes. Diabetes Obes Metab . 2017;19:1630–1634.28417532
   PubMed Web of Science ®Google Scholar
• Llauradó G , Sevastianova K , Sädevirta S , et al. Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes. J Clin Endocrinol Metab . 2015;100:607–616. doi:10.1210/jc.2014-3050 25405502
   PubMed Web of Science ®Google Scholar
• Al-Hussaini AA , Sulaiman N , Al-Zahrani M , Alenazi A , Khan M . Prevalence of liver disease among type 1 diabetic children. J Pediatr Gastroenterol Nutr . 2010;51(Suppl 2):E57.
   Google Scholar
• El-Karaksy HM , Anwar G , Esmat G , et al. Prevalence of hepatic abnormalities in a cohort of Egyptian children with type 1 diabetes mellitus. Pediatr Diabetes . 2010;11:462–470. doi:10.1111/j.1399-5448.2009.00627.x 20042012
   PubMed Web of Science ®Google Scholar
• Im SS , Kang SY , Kim SY , et al. Glucose-stimulated upregulation of GLUT2 gene is mediated by sterol response element-binding protein-1c in the hepatocytes. Diabetes . 2005;54:1684–1691. doi:10.2337/diabetes.54.6.1684 15919789
   PubMed Web of Science ®Google Scholar
• Targher G , Lonardo A , Byrne CD . Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nat Rev Endocrinol . 2017;14:99–114. doi:10.1038/nrendo.2017.173 29286050
   PubMed Web of Science ®Google Scholar
• Targher G , Byrne CD . Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. Nat Rev Nephrol . 2017;13:297–310. doi:10.1038/nrneph.2017.16 28218263
   PubMed Web of Science ®Google Scholar